Table 7.
Prognostic value of suPAR within the rule-in definition.
| RULE-IN-Definition | Death | Incident Non-Fatal AMI | Coronary Intervention | Cardiac Rehospitalisation |
|---|---|---|---|---|
| hs-TnI 1 h > 6 ng/L AND hs-TnI increase ≥ 12 ng/L compared to hs-TnI 0h |
N = 11/177 6.78% |
N = 3/177 2.08% |
N = 16/177 9.57% |
N = 46/177 28.82% |
| hs-TnI 1 h > 6 ng/L AND hs-TnI increase ≥ 12 ng/L compared to hs-TnI 0 h AND suPAR 0 h ≥ 3.7 ng/mL |
N = 9/93 10.28% |
N = 2/93 3.03% |
N = 8/93 9.36% |
N = 23/93 28.00% |
| suPAR 0 h ≥ 3.7 ng/mL |
N = 44/533 9.91% |
N = 7/533 1.66% |
N = 28/533 5.83% |
N = 120/533 26.60% |
AMI = acute myocardial infarction, hs-TnI = high-sensitivity troponin I, suPAR = soluble urokinase-type plasminogen activator receptor.